Soonbum Park et al. found that knocking down the P53 tumor suppressor gene resulted in a shift from non-muscle-invasive to muscle-invasive BC, as well as an increase in cancer-related molecular pathways, including pro-inflammatory pathways (Park et al., 2021). The gene discussed is TP53; the disease is breast cancer.